Agios Pharmaceuticals Inc
SWB:8AP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Agios Pharmaceuticals Inc
SWB:8AP
|
US |
|
S
|
Smart Digital Group Ltd
NASDAQ:SDM
|
SG |
|
V
|
Vestas Wind Systems A/S
DUS:VWSB
|
DK |
|
F
|
Fresenius SE & Co KGaA
XMUN:FRE
|
DE |
|
Tissue Regenix Group PLC
LSE:TRX
|
UK |
|
Z
|
Zalando SE
DUS:ZAL
|
DE |
|
A
|
American International Group Inc
XHAM:AINN
|
US |
Wall St Price Targets
8AP Price Targets Summary
Agios Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for 8AP is 36.57 EUR with a low forecast of 24.39 EUR and a high forecast of 53.43 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 8AP's stock price target?
Price Target
36.57
EUR
According to Wall Street analysts, the average 1-year price target for 8AP is 36.57 EUR with a low forecast of 24.39 EUR and a high forecast of 53.43 EUR.
What is the Revenue forecast for Agios Pharmaceuticals Inc?
Projected CAGR
96%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 3 years is 96%.
What is the Gross Profit forecast for Agios Pharmaceuticals Inc?
Projected CAGR
30%
The compound annual growth rate for Gross Profit over the next 3 years is 30%.
